Kumar V, Wahane A, Tham M, Somlo S, Gupta A, Bahal R
Mol Ther. 2024; 32(12):4383-4400.
PMID: 39532098
PMC: 11638880.
DOI: 10.1016/j.ymthe.2024.10.020.
Yadav S, Dhuri K, Gamiotea-Turro D, Cormier M, Patel V, Yadawa A
Mol Ther Nucleic Acids. 2024; 35(4):102355.
PMID: 39507400
PMC: 11539414.
DOI: 10.1016/j.omtn.2024.102355.
MacLelland V, Kravitz M, Gupta A
Mol Ther Nucleic Acids. 2024; 35(1):102086.
PMID: 38204913
PMC: 10777018.
DOI: 10.1016/j.omtn.2023.102086.
Gasparello J, Papi C, Zurlo M, Volpi S, Gambari R, Corradini R
Pharmaceutics. 2023; 15(8).
PMID: 37631335
PMC: 10460053.
DOI: 10.3390/pharmaceutics15082121.
Zheng H, Clausse V, Amarasekara H, Mazur S, Botos I, Appella D
JACS Au. 2023; 3(7):1952-1964.
PMID: 37502163
PMC: 10369417.
DOI: 10.1021/jacsau.3c00198.
Diatom-Based Nanomedicine for Colorectal Cancer Treatment: New Approaches for Old Challenges.
Tramontano C, De Stefano L, Rea I
Mar Drugs. 2023; 21(5).
PMID: 37233460
PMC: 10222510.
DOI: 10.3390/md21050266.
Drug Discovery Perspectives of Antisense Oligonucleotides.
Kim Y
Biomol Ther (Seoul). 2023; 31(3):241-252.
PMID: 36859811
PMC: 10129852.
DOI: 10.4062/biomolther.2023.001.
Thyclotides, tetrahydrofuran-modified peptide nucleic acids that efficiently penetrate cells and inhibit microRNA-21.
Clausse V, Zheng H, Amarasekara H, Kruhlak M, Appella D
Nucleic Acids Res. 2022; 50(19):10839-10856.
PMID: 36215040
PMC: 9638920.
DOI: 10.1093/nar/gkac864.
Surface conjugation of antibodies improves nanoparticle uptake in bronchial epithelial cells.
Luks V, Mandl H, DiRito J, Barone C, Freedman-Weiss M, Ricciardi A
PLoS One. 2022; 17(4):e0266218.
PMID: 35385514
PMC: 8986008.
DOI: 10.1371/journal.pone.0266218.
An Efficient Approach for the Design and Synthesis of Antimicrobial Peptide-Peptide Nucleic Acid Conjugates.
Patil N, Thombare V, Li R, He X, Lu J, Yu H
Front Chem. 2022; 10:843163.
PMID: 35372270
PMC: 8964499.
DOI: 10.3389/fchem.2022.843163.
Inhibiting mutant KRAS G12D gene expression using novel peptide nucleic acid-based antisense: A potential new drug candidate for pancreatic cancer.
Shai A, Galouk E, Miari R, Tareef H, Sammar M, Zeidan M
Oncol Lett. 2022; 23(4):130.
PMID: 35251350
PMC: 8895471.
DOI: 10.3892/ol.2022.13250.
Head on Comparison of Self- and Nano-assemblies of Gamma Peptide Nucleic Acid Amphiphiles.
Malik S, Kumar V, Liu C, Shih K, Krueger S, Nieh M
Adv Funct Mater. 2022; 32(7).
PMID: 35210986
PMC: 8863176.
DOI: 10.1002/adfm.202109552.
Therapeutic Potential of Chemically Modified, Synthetic, Triplex Peptide Nucleic Acid-Based Oncomir Inhibitors for Cancer Therapy.
Dhuri K, Gaddam R, Vikram A, Slack F, Bahal R
Cancer Res. 2021; 81(22):5613-5624.
PMID: 34548334
PMC: 8595710.
DOI: 10.1158/0008-5472.CAN-21-0736.
Non-cationic Material Design for Nucleic Acid Delivery.
Jiang Z, Thayumanavan S
Adv Ther (Weinh). 2021; 3(3).
PMID: 34164572
PMC: 8218910.
DOI: 10.1002/adtp.201900206.
Nanoparticle Delivered Anti-miR-141-3p for Stroke Therapy.
Dhuri K, Vyas R, Blumenfeld L, Verma R, Bahal R
Cells. 2021; 10(5).
PMID: 33922958
PMC: 8145654.
DOI: 10.3390/cells10051011.
State-of-the-art progress of switch fluorescence biosensors based on metal-organic frameworks and nucleic acids.
Huo Y, Liu S, Gao Z, Ning B, Wang Y
Mikrochim Acta. 2021; 188(5):168.
PMID: 33884514
DOI: 10.1007/s00604-021-04827-9.
The NIH Somatic Cell Genome Editing program.
Saha K, Sontheimer E, Brooks P, Dwinell M, Gersbach C, Liu D
Nature. 2021; 592(7853):195-204.
PMID: 33828315
PMC: 8026397.
DOI: 10.1038/s41586-021-03191-1.
Facile accelerated specific therapeutic (FAST) platform develops antisense therapies to counter multidrug-resistant bacteria.
Eller K, Aunins T, Courtney C, Campos J, Otoupal P, Erickson K
Commun Biol. 2021; 4(1):331.
PMID: 33712689
PMC: 7955031.
DOI: 10.1038/s42003-021-01856-1.
Multifunctional Delivery Systems for Peptide Nucleic Acids.
Volpi S, Cancelli U, Neri M, Corradini R
Pharmaceuticals (Basel). 2020; 14(1).
PMID: 33375595
PMC: 7823687.
DOI: 10.3390/ph14010014.
Next generation miRNA inhibition using short anti-seed PNAs encapsulated in PLGA nanoparticles.
Malik S, Lim J, Slack F, Braddock D, Bahal R
J Control Release. 2020; 327:406-419.
PMID: 32835710
PMC: 7606596.
DOI: 10.1016/j.jconrel.2020.08.026.